P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38 MONOCLONAL ANTIBODY: A RETRO-PROSPECTIVE ITALIAN OBSERVATIONAL STUDY

Detalles Bibliográficos
Autores principales: Offidani, M., Morè, S., Cavo, M., Derudas, D., Di Raimondo, F., Cuneo, A., Baldini, L., Della Pepa, R., Musso, M., Boccadoro, M., Musto, P., Belotti, A., Fioritoni, F., Di Renzo, N., Mele, A., Gamberi, B., De Paoli, L., Zambello, R., Grammatico, S., Brociner, M., Fazio, F., Petrucci, M. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171581/
http://dx.doi.org/10.1097/01.HS9.0000936272.88286.72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171581/
http://dx.doi.org/10.1097/01.HS9.0000936272.88286.72

Ejemplares similares